Breast cancer is the most common cancer in women and the 2nd-leading cause of cancer-related deaths in women in the United States. Early detection and improved pathology-specific treatments have resulted in a decrease in death rates. Several organizations provide recommendations regarding screening for specific age and risk groups. Screenings include breast examination, mammography, magnetic resonance imaging (MRI), and ultrasound (US).
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer is a disease characterized by malignant transformationTransformationChange brought about to an organism’s genetic composition by unidirectional transfer (transfection; transduction, genetic; conjugation, genetic, etc.) and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell’s genome.Bacteriology of the epithelial cells of the breast.
Epidemiology[4,5,8]
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer is the most common cancer in women worldwide.
Accounts for 29% of all malignant diseases among women in the United States
IncidenceIncidenceThe number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from prevalence, which refers to all cases in the population at a given time.Measures of Disease Frequency: 125 cases per 100,000 women
Risk increases with age, with 90% of cases occurring in women > 40 years of age
Male breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer accounts for < 1% of total cases.
An important cause of death in women:
United States: the 2nd-leading cause of cancer-related deaths
Developing countries: the leading cause of cancer-related deaths
Early detection and improved treatments have reduced death rates.
Goal of screeningScreeningPreoperative Care: detect preclinical disease in healthy, asymptomatic patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship
Best for:
Situations in which early detection and treatment reduce mortalityMortalityAll deaths reported in a given population.Measures of Health Status as compared with later diagnosis and treatment
PatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship most likely to develop the disease
Process:
Assess a patient’s risk for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer,
Follow-up abnormal screeningScreeningPreoperative Care test results with further testing based on initial results
Risk factors for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer[4]
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer in 1st- or 2nd-degree relatives (mother, grandmother, sister)
Ashkenazi Jewish descent
Hormonal influences:
Long hormone exposure due to:
Early menarcheMenarcheThe first menstrual cycle marked by the initiation of menstruation.Menstrual Cycle
Late menopauseMenopauseMenopause is a physiologic process in women characterized by the permanent cessation of menstruation that occurs after the loss of ovarian activity. Menopause can only be diagnosed retrospectively, after 12 months without menstrual bleeding. Menopause
Higher age at 1st delivery (> 30 years of age)
Nulliparity
Hormone replacement therapyHormone Replacement TherapyHormone replacement therapy (HRT) is used to treat symptoms associated with female menopause and in combination to suppress ovulation. Risks and side effects include uterine bleeding, predisposition to cancer, breast tenderness, hyperpigmentation, migraine headaches, hypertension, bloating, and mood changes.Noncontraceptive Estrogen and Progestins after menopauseMenopauseMenopause is a physiologic process in women characterized by the permanent cessation of menstruation that occurs after the loss of ovarian activity. Menopause can only be diagnosed retrospectively, after 12 months without menstrual bleeding. Menopause (> 5 years)
Note: BreastfeedingBreastfeedingBreastfeeding is often the primary source of nutrition for the newborn. During pregnancy, hormonal stimulation causes the number and size of mammary glands in the breast to significantly increase. After delivery, prolactin stimulates milk production, while oxytocin stimulates milk expulsion through the lactiferous ducts, where it is sucked out through the nipple by the infant. Breastfeeding for at least 6 months decreases the risk of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer.
BRCA1(on chromosomeChromosomeIn a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell.Basic Terms of Genetics 17q)
BRCA2 (on chromosomeChromosomeIn a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell.Basic Terms of Genetics 13q)
p53(on chromosomeChromosomeIn a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell.Basic Terms of Genetics 17)
Increasing age
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer on the contralateral side
Prior breast biopsyBiopsyRemoval and pathologic examination of specimens from the living body.Ewing Sarcoma with:
Dense breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy
History of chest radiationRadiationEmission or propagation of acoustic waves (sound), electromagnetic energy waves (such as light; radio waves; gamma rays; or x-rays), or a stream of subatomic particles (such as electrons; neutrons; protons; or alpha particles).Osteosarcoma as a young woman (10‒30 years old)
Lifestyle factors that increase the risk:
High-fat diet
ObesityObesityObesity is a condition associated with excess body weight, specifically with the deposition of excessive adipose tissue. Obesity is considered a global epidemic. Major influences come from the western diet and sedentary lifestyles, but the exact mechanisms likely include a mixture of genetic and environmental factors. Obesity (especially after menopauseMenopauseMenopause is a physiologic process in women characterized by the permanent cessation of menstruation that occurs after the loss of ovarian activity. Menopause can only be diagnosed retrospectively, after 12 months without menstrual bleeding. Menopause)
Heavy alcohol use
Tobacco
Mnemonic:
BReast-CACACondylomata acuminata are a clinical manifestation of genital HPV infection. Condylomata acuminata are described as raised, pearly, flesh-colored, papular, cauliflower-like lesions seen in the anogenital region that may cause itching, pain, or bleeding.Condylomata Acuminata (Genital Warts)ncer 1 and 2: BRCA1 and BRCA2 are the mutated genesGenesA category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.DNA Types and Structure in breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer.
Initial risk assessmentRisk assessmentThe qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.Preoperative Care[4,12]
Details of the patient’s medical and personal history are needed to determine their risk:
Known carrierCarrierVaccination of a gene mutationGene MutationMyotonic Dystrophies for breast or ovarian cancerOvarian cancerOvarian cancer is a malignant tumor arising from the ovarian tissue and is classified according to the type of tissue from which it originates. The 3 major types of ovarian cancer are epithelial ovarian carcinomas (EOCs), ovarian germ cell tumors (OGCTs), and sex cord-stromal tumors (SCSTs). Ovarian Cancer:
If not known, determine the need for genetic testingGenetic TestingDetection of a mutation; genotype; karyotype; or specific alleles associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.Myotonic Dystrophies based on risk factors.
Genetic testingGenetic TestingDetection of a mutation; genotype; karyotype; or specific alleles associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.Myotonic Dystrophies for hereditary breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer is recommended when specific criteria are metMETPreoperative Care (criteria vary slightly according to organization (see below)).
Mammographic breast density
High-risk lesion on a previous breast biopsyBiopsyRemoval and pathologic examination of specimens from the living body.Ewing Sarcoma
History of chest radiotherapy (age 10–30 years)
A patient’s risk for developing breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer can be classified as:
Average:
Have none of the above risk factors (most patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship)
Lifetime risk < 15%
Moderate:
Most women with a family historyFamily HistoryAdult Health Maintenance of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer in a 1st-degree relative, but no known genetic syndrome
Lifetime risk 15%‒20%
High:
PatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship with:
A known genetic predisposition
Personal history of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
History of chest irradiation between the ages of 10 and 30 years
Lifetime risk > 20%
Determining the need for genetic evaluation:
Criteria from the National Comprehensive Cancer Network (NCCN),[10] the American College of Obstetricians and Gynecologists (ACOG), and the Society of Gynecologic Oncologists (SGO)[9]for genetic evaluation of hereditary breast and ovarian cancerOvarian cancerOvarian cancer is a malignant tumor arising from the ovarian tissue and is classified according to the type of tissue from which it originates. The 3 major types of ovarian cancer are epithelial ovarian carcinomas (EOCs), ovarian germ cell tumors (OGCTs), and sex cord-stromal tumors (SCSTs). Ovarian Cancer include:
Individuals who are diagnosed with breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer OR who have a 1st-degree (or several close) relatives diagnosed with any of the following:
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer at ≤ 45 years of age
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer at ≤ 50 years of age with unknown family historyFamily HistoryAdult Health Maintenance
Triple-negative (ER‒, PR‒, HER2HER2A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of adenocarcinomas. It has extensive homology to and heterodimerizes with the EGF receptor, the ERBB-3 receptor, and the ERBB-4 receptor. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.Targeted and Other Nontraditional Antineoplastic Therapy‒) breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer at ≤ 60 years of age
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer at any age with Ashkenazi Jewish ancestry
≥ 2 primary breast cancers in the same individual
Epithelial ovarian, tubal, or peritoneal cancer (ever)
Pancreatic cancer
Metastatic prostateProstateThe prostate is a gland in the male reproductive system. The gland surrounds the bladder neck and a portion of the urethra. The prostate is an exocrine gland that produces a weakly acidic secretion, which accounts for roughly 20% of the seminal fluid. cancer
Individual unaffected by cancer but with 1 of the following factors that increase likelihood of an inherited risk of breast, tubal, ovarian, or peritoneal cancer:
Close relatives with criteria listed above
Close relative carrying a known BRCA1 or BRCA2 mutationMutationGenetic mutations are errors in DNA that can cause protein misfolding and dysfunction. There are various types of mutations, including chromosomal, point, frameshift, and expansion mutations. Types of Mutations
Close relative with male breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer at any age PLUS 1 of the following:
≥ 1 close relative with:
Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer at ≤ 50 years of age
Epithelial ovarian, tubal, or peritoneal cancer (ever)
Pancreatic cancer
Male breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer or high-grade (Gleason score ≥ 7) /metastatic prostateProstateThe prostate is a gland in the male reproductive system. The gland surrounds the bladder neck and a portion of the urethra. The prostate is an exocrine gland that produces a weakly acidic secretion, which accounts for roughly 20% of the seminal fluid. cancer
≥ 2 close relatives with breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer at any age
Note: Close relatives are defined as 1st degree (parent, sibling, children), 2nd degree (grandparent, grandchild, aunt/uncle, niece/nephew, half-sibling), or 3rd degree (1st cousin, great-grandparent, great-grandchild).
Familial risk assessmentRisk assessmentThe qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.Preoperative Care tools:
Help determine need for in-depth genetic counselingGenetic CounselingAn educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.Myotonic Dystrophies for patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship with personal history or family historyFamily HistoryAdult Health Maintenance of breast, ovarian, tubal, or peritoneal cancer
Tools include:[2]
Ontario Family HistoryFamily HistoryAdult Health MaintenanceRisk AssessmentRisk assessmentThe qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.Preoperative Care Tool
PedigreePedigreeThe record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.Basic Terms of Genetics assessment tool
International Breast CancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer Intervention Study (IBIS) model (also known as Tyrer-Cuzick model)[3]
Recommended by the American Society of Breast Surgeons (ASBrS)
Takes into account family and personal history of cancer, breast density, and biopsyBiopsyRemoval and pathologic examination of specimens from the living body.Ewing Sarcoma results
BRCAPRO (calculates the probabilityProbabilityProbability is a mathematical tool used to study randomness and provide predictions about the likelihood of something happening. There are several basic rules of probability that can be used to help determine the probability of multiple events happening together, separately, or sequentially.Basics of Probability of carrying BRCA1 and/or BRCA2mutationMutationGenetic mutations are errors in DNA that can cause protein misfolding and dysfunction. There are various types of mutations, including chromosomal, point, frameshift, and expansion mutations. Types of Mutations)
Positive resultsshould lead to genetic counselingGenetic CounselingAn educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.Myotonic Dystrophies and potentially genetic testingGenetic TestingDetection of a mutation; genotype; karyotype; or specific alleles associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.Myotonic Dystrophies.
Genetic counselingGenetic CounselingAn educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.Myotonic Dystrophies and testing are not recommended for women with no personal or family historyFamily HistoryAdult Health Maintenance or ancestry associated with BRCA1 or BRCA2.
Risk prediction models[3,4]
Prediction models calculating the risk of developing breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer (and in some, gynecologic cancer):
Indicated for patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship with no personal or strong family historyFamily HistoryAdult Health Maintenance of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer (including ductal or lobular carcinoma in situ)
Takes into account age, ethnicity, age at menarcheMenarcheThe first menstrual cycle marked by the initiation of menstruation.Menstrual Cycle, parityParityThe number of offspring a female has borne. It is contrasted with gravidity, which refers to the number of pregnancies, regardless of outcome.Pregnancy: Diagnosis, Physiology, and Care, and family historyFamily HistoryAdult Health Maintenance of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Less precise for older women
Cannot be used in certain subgroups (such as patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship with genetic mutationsGenetic MutationsCarcinogenesis, e.g., BRCA1 or BRCA2 mutations)
CanRisk Web Tool (previously known as BOADICEA (Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm)):
From the given family historyFamily HistoryAdult Health Maintenance, the tool calculates the risks of breast or ovarian cancerOvarian cancerOvarian cancer is a malignant tumor arising from the ovarian tissue and is classified according to the type of tissue from which it originates. The 3 major types of ovarian cancer are epithelial ovarian carcinomas (EOCs), ovarian germ cell tumors (OGCTs), and sex cord-stromal tumors (SCSTs). Ovarian Cancer in women.
Also used to calculate the probabilityProbabilityProbability is a mathematical tool used to study randomness and provide predictions about the likelihood of something happening. There are several basic rules of probability that can be used to help determine the probability of multiple events happening together, separately, or sequentially.Basics of Probability of being BRCA1 or BRCA2 carriersCarriersThe Cell: Cell Membrane
Claus model: uses age at diagnosis of 1st- and 2nd-degree relatives (with a history of breast and ovarian cancerOvarian cancerOvarian cancer is a malignant tumor arising from the ovarian tissue and is classified according to the type of tissue from which it originates. The 3 major types of ovarian cancer are epithelial ovarian carcinomas (EOCs), ovarian germ cell tumors (OGCTs), and sex cord-stromal tumors (SCSTs). Ovarian Cancer) to estimate the lifetime risk for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Breast examinationBreast examinationPhysical examination of the breasts is important both in the evaluation of a breast complaint and screening for asymptomatic breast pathology such as a breast mass. The examination involves inspection of the breasts to look for asymmetry or skin/nipple changes, as well as palpation of the breasts, nipples, and axilla. Coupled with medical history, the outcome of a breast examination can be normal, lead to a clinical diagnosis (e.g., infection), or require additional diagnostic evaluation.Examination of the Breast
Self-examination:[4]
The regularRegularInsulin, repetitive inspectionInspectionDermatologic Examination of one’s own breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy for the purpose of detecting breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Generally discouraged
Can lead to unnecessary procedures (e.g., mammograms and biopsies)
ACOG encourages teaching women “breast awareness” over self-exams[4]
Breast awareness: A woman’s awareness of the normal appearance and feel of her breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy
Women should be educated about signs and symptoms of potential cancer, including a new massMassThree-dimensional lesion that occupies a space within the breastImaging of the Breast, nippleNippleThe conic organs which usually give outlet to milk from the mammary glands.Examination of the Breast discharge, rednessRednessInflammation, or painPainAn unpleasant sensation induced by noxious stimuli which are detected by nerve endings of nociceptive neurons.Pain: Types and Pathways.
PatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship should notify their healthcare provider if they notice a change.
Clinical examination:[1,3–6]
A clinical breast exam performed by a healthcare provider
Generally not recommendedas a screeningScreeningPreoperative Care exam for asymptomatic average-risk women (some societies note it may be used as an adjunct only)
Utilized in the case of:
Women with a high risk (initial age differs depending on risk factors)
Any breast complaints or abnormalities
Low-resource settings
Localizing breast lesions:
If there is a vague or large area, then the affected breast quadrant may be noted.
If there is a focal lesion, then the lesion will be localized by the clock face position and distance from the nippleNippleThe conic organs which usually give outlet to milk from the mammary glands.Examination of the Breast.
MammographyMammographyRadiographic examination of the breast.Breast Cancer Screening is the most effective method of detecting early breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer, consistently demonstrating a 20%–40% decrease in mortalityMortalityAll deaths reported in a given population.Measures of Health Status among screened women:
Digital mammographyDigital MammographyBreast Cancer Screening (2-D mammographyMammographyRadiographic examination of the breast.Breast Cancer Screening): preferred for dense breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy (approximately 50% of all women)
Digital breast tomosynthesisDigital breast tomosynthesisPremature separation of the normally implanted placenta from the uterus. Signs of varying degree of severity include uterine bleeding, uterine muscle hypertonia, and fetal distress or fetal death.Breast Cancer Screening (DBT; 3-D mammography3-D mammographyPremature separation of the normally implanted placenta from the uterus. Signs of varying degree of severity include uterine bleeding, uterine muscle hypertonia, and fetal distress or fetal death.Breast Cancer Screening):
Takes images from many angles to obtain a 3-dimensional picture
An artificial intelligence (AI) technique that uses pattern recognition to highlight suspicious features and marks the features for the radiologist to review
Performed on a woman with no symptoms or signs of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Two standard views (+/– additional views) of each breast are obtained.
PatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship with breast implants:
Involves 4 views (instead of the usual 2) per breast
Breast cancer screening: a woman undergoing screening mammography
Image: “Mammogram” by the National Cancer Institute. License: Public domain.
Benign findings on a mammogram: screening mammography, right and left mediolateral oblique views, showing sparse, bilateral, punctate vascular (blood-vessel associated/benign) calcifications (Breast Imaging Reporting and Data System (BI-RADS) 2)
Imagem: “Fat necrosis associated with the use of oral anticoagulant therapy:atypical mammographic findings” por Radiologia Brasileira. Licença: CC BY 4.0, edited by Lecturio.
Mammography is performed for screening and early detection of breast cancer:
Left: Mammographic image of normal breast tissue
Right: Mammographic image of cancerous breast tissue
Image: “Mammo breast cancer” by National Cancer Institute. License: Public Domain
A mass on screening mammography Image shows a circumscribed mass in the 3 o’clock position of the right breast.
Image: “Cylindroma of the breast: A case report and review of the literature” by Mahmoud A, Hill DH, O’Sullivan MJ, Bennett MW. License: CC BY 2.0.
Magnetic resonance imaging (MRI)[11]
Indicated as supplementary screeningScreeningPreoperative Care along with mammographyMammographyRadiographic examination of the breast.Breast Cancer Screening in women with a high risk of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer:
BRCA1 or BRCA2 mutations
Strong family histories of breast and/or ovarian cancerOvarian cancerOvarian cancer is a malignant tumor arising from the ovarian tissue and is classified according to the type of tissue from which it originates. The 3 major types of ovarian cancer are epithelial ovarian carcinomas (EOCs), ovarian germ cell tumors (OGCTs), and sex cord-stromal tumors (SCSTs). Ovarian Cancer
History of chest irradiation between the ages of 10 and 30
May be appropriate in women at intermediate risk of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer:[11]
Personal history of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Higher false positiveFalse positiveAn FP test result indicates that a person has the disease when they do not.Epidemiological Values of Diagnostic Tests rates in women with dense breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy, leading to unneeded biopsies
Mammography and breast MRI Image A shows mammography of the left breast in a BRCA1 gene mutation carrier. Note the extremely dense breast tissue. Image B demonstrates an MRI with an enhancing mass (arrow) in the upper left breast that was occult on the mammogram.
Image: “MRI for breast cancer: Current indications” by Ojeda-Fournier H, Comstock CE. License: CC BY 2.0.
1st-choice imaging method for evaluating a breast massMassThree-dimensional lesion that occupies a space within the breastImaging of the Breast in women < 30 years of age
Can be considered as an adjunct in patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship with dense breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy
Evaluating the breast: use of US imaging
Image: “Retroareolar Carcinomas in Breast Ultrasound: Pearls and Pitfalls” by Cancers. License: CC BY 4.0, edited by Lecturio.
Mammography and breast US A: Mammography shows a round, high-density mass in the lower inner quadrant of the right breast. B: Ultrasonography follow-up shows a 1.3-cm irregularly shaped, hypoechoic mass in the breast.
Image: “Secretory breast carcinoma: A report of three cases and a review of the literature” by Lee SG, Jung SP, Lee HY, Kim S, Kim HY, Kim I, Bae JW. License: CC BY 3.0.
Provides a category from 0 to 6 that is associated with specific management recommendations
Standardizes imaging reports
Components of the BI-RADs report include:
Indication for the study
Prior images reviewed
Assessment of breast density:
1: BreastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy are almost entirely fatty
2: Scattered areas of fibroglandular density
3: Heterogeneously dense breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy, which may obscure small masses
4: Extremely dense breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy, which lowers the sensitivity of mammographyMammographyRadiographic examination of the breast.Breast Cancer Screening
Description of abnormalities
Summary, including the final BI-RADs assessment category (0‒6)
Management for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
aFollow-up guidelines listed here are for asymptomatic individuals who underwent routine screening mammography examinations.
Follow-up can differ when imaging is performed in symptomatic individuals (e.g., patient with a breast mass).
Note: A negative report should not rule out malignancy if there is a high clinical suspicion. Consider follow-up with ultrasonography.
The primary reason for the variance in recommendation is that the societies and organizations weigh benefits and harms slightly differently from one another.
This, however, can be very confusing for patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship (and providers), so counseling women in order to allow for shared decision-making is typically encouraged.
VariableVariableVariables represent information about something that can change. The design of the measurement scales, or of the methods for obtaining information, will determine the data gathered and the characteristics of that data. As a result, a variable can be qualitative or quantitative, and may be further classified into subgroups.Types of Variables
Fewer breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer deaths
Overdiagnosis refers to breast cancers identified on screening that would not have been a threat to a patient’s health during her lifetime.[1]
Table: Breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast CancerscreeningScreeningPreoperative Care guidelines for average-risk individuals
Clinical breast examinationBreast examinationPhysical examination of the breasts is important both in the evaluation of a breast complaint and screening for asymptomatic breast pathology such as a breast mass. The examination involves inspection of the breasts to look for asymmetry or skin/nipple changes, as well as palpation of the breasts, nipples, and axilla. Coupled with medical history, the outcome of a breast examination can be normal, lead to a clinical diagnosis (e.g., infection), or require additional diagnostic evaluation.Examination of the Breast
USPSTF[1,27]
Ages 40–49: individualizea,b
Ages 50–74: every 2 years
Ages > 75: insufficient evidence
Insufficient evidence
ACP[26]
Ages 40–49: individualizea
Ages 50–74: every 2 years
Ages ≥ 75: Discontinue screeningScreeningPreoperative Care if life expectancyLife expectancyBased on known statistical data, the number of years which any person of a given age may reasonably expected to live.Population Pyramids is < 10 years.
Not recommended
ACS[5,6]
May offer at age 40; start at age 45.
Ages 45–54: annually
Ages 55 and above: every 1–2 years
Continue if life expectancyLife expectancyBased on known statistical data, the number of years which any person of a given age may reasonably expected to live.Population Pyramids is ≥ 10 years.
Not recommended
Supports breast self-awareness.
American Society of Breast Surgeons[3]
Ages ≥ 40: annually
Preferred method: DBT
Not recommended
ACOG[4]
May offer at age 40.
Start no later than age 50: every 1–2 years.
Ages > 75: Assess health, longevity, and discontinuation options.
DBT when prior exams have detected dense breast tissue
Not recommended
WHO[9]
Ages 50–69 years: every 2 years
Ages 40–49 and 70–75: screeningScreeningPreoperative Care programs only in well-resourced settings in the context of researchResearchCritical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws.Conflict of Interest
Recommended in low-resource settings with weak health systemsHealth systemsThe complexity of health systems and the delivery of healthcare has resulted in the growing field of health systems science, which has now joined basic and clinical sciences as the 3rd pillar of medical education. Health systems science allows for an understanding of the framework in which care providers practice, and in comprehension of the interconnected components of care delivery.Healthcare System
aDiscuss breast cancer screening, risks, benefits, and potential for unnecessary procedures. For patients who choose to
initiate screening, mammography is performed every 1–2 years. bThe USPSTF has issued a draft recommendation statement recommending screening to begin at age 40
and continue every other year. More research is required regarding additional screening with ultrasound or MRI for women with dense breasts.
Public comment and finalized recommendation are pending.
ACOG: American College of Obstetricians and Gynecologists
ACP: American College of Physicians
ACS: American Cancer Society
DBT: digital breast tomosynthesis (i.e., 3D mammography)
NCCN: National Comprehensive Cancer Network
USPSTF: U.S. Preventive Services Task Force
Moderate risk[12]
A similar approach to average-risk patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship
High-risk individuals are defined by the ASBrS and the NCCN as people with:[3]
A BRCAgene mutationGene MutationMyotonic Dystrophies (or other hereditary mutations known to increase the risk of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer)
A very strong family historyFamily HistoryAdult Health Maintenance of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer and who have not undergone genetic testingGenetic TestingDetection of a mutation; genotype; karyotype; or specific alleles associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.Myotonic Dystrophies
A history of chest irradiation between ages 10 and 30
> 20% estimated lifetime risk of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer based on risk assessmentRisk assessmentThe qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.Preoperative Care tools (e.g., IBIS/Tyrer-Cuzick, BRCAPro, etcETCThe electron transport chain (ETC) sends electrons through a series of proteins, which generate an electrochemical proton gradient that produces energy in the form of adenosine triphosphate (ATP).Electron Transport Chain (ETC).)
Exams are typically alternated every 6 months (e.g., mammographyMammographyRadiographic examination of the breast.Breast Cancer Screening annually in January with MRI annually in July).
SmokingSmokingWillful or deliberate act of inhaling and exhaling smoke from burning substances or agents held by hand.Interstitial Lung Diseases cessation
There is no evidence that dietary changes reduce risk.
Chemoprevention:[15,20]
USPSTF:[15] Risk-reducing medications are recommended for high-risk women ≥ 35 years of age (for a total of 5 years).
Considered in women at a high risk of breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Selective estrogenEstrogenCompounds that interact with estrogen receptors in target tissues to bring about the effects similar to those of estradiol. Estrogens stimulate the female reproductive organs, and the development of secondary female sex characteristics. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.Ovaries: AnatomyreceptorReceptorReceptors are proteins located either on the surface of or within a cell that can bind to signaling molecules known as ligands (e.g., hormones) and cause some type of response within the cell.Receptors modulators (SERMsSERMsA structurally diverse group of compounds distinguished from estrogens by their ability to bind and activate estrogen receptors but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the endometrium or second generation based on their patterns of tissue specificity.Antiestrogens):
TamoxifenTamoxifenOne of the selective estrogen receptor modulators with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the endometrium.Antiestrogens 20 mg by mouth once daily for 5 years
RaloxifeneRaloxifeneA second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.Other Antiresorptive Drugs 60 mg by mouth once daily for 5 years (or longer in women with osteoporosisOsteoporosisOsteoporosis refers to a decrease in bone mass and density leading to an increased number of fractures. There are 2 forms of osteoporosis: primary, which is commonly postmenopausal or senile; and secondary, which is a manifestation of immobilization, underlying medical disorders, or long-term use of certain medications. Osteoporosis)
Choosing a SERM: RaloxifeneRaloxifeneA second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.Other Antiresorptive Drugs results in a smaller reduction of new breast cancers as compared with tamoxifenTamoxifenOne of the selective estrogen receptor modulators with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the endometrium.Antiestrogens, but it has a lower risk of endometrial cancerEndometrial CancerEndometrial carcinoma (EC) is the most common gynecologic malignancy in the developed world, and it has several histologic types. Endometrioid carcinoma (known as type 1 EC) typically develops from atypical endometrial hyperplasia, is hormonally responsive, and carries a favorable prognosis.Endometrial Hyperplasia and Endometrial Cancer and thrombosisThrombosisFormation and development of a thrombus or blood clot in the blood vessel.Epidemic Typhus and is also a treatment for osteoporosisOsteoporosisOsteoporosis refers to a decrease in bone mass and density leading to an increased number of fractures. There are 2 forms of osteoporosis: primary, which is commonly postmenopausal or senile; and secondary, which is a manifestation of immobilization, underlying medical disorders, or long-term use of certain medications. Osteoporosis.[20]
AromataseAromataseAn enzyme that catalyzes the desaturation (aromatization) of the ring a of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the cyp19 gene, and functions in complex with NADPH-ferrihemoprotein reductase in the cytochrome p450 system.Adipose Tissue: Histology inhibitor:
AnastrozoleAnastrozoleA nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of estrogen nuclear receptor-positive breast cancer in postmenopausal women.Antiestrogens 1 mg once daily for 5 years
Off-label use for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer risk reduction
Women should be counseled on the potential morbidityMorbidityThe proportion of patients with a particular disease during a given year per given unit of population.Measures of Health Status of surgical procedures (surgical menopauseSurgical MenopauseMenopause, libido, body image).
Other genetic mutationsGenetic MutationsCarcinogenesis that carry a greater lifetime risk for developing breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer
Does not completely eliminate the risk of cancer
May be done in conjunction with salpingo-oophorectomy to reduce ovarian cancerOvarian cancerOvarian cancer is a malignant tumor arising from the ovarian tissue and is classified according to the type of tissue from which it originates. The 3 major types of ovarian cancer are epithelial ovarian carcinomas (EOCs), ovarian germ cell tumors (OGCTs), and sex cord-stromal tumors (SCSTs). Ovarian Cancer risk
Screening for Special Populations
PatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship with dense breast tissue[3,7]
ASBrS and the European Commission both recommend DBT for patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship with dense breastsBreastsThe breasts are found on the anterior thoracic wall and consist of mammary glands surrounded by connective tissue. The mammary glands are modified apocrine sweat glands that produce milk, which serves as nutrition for infants. Breasts are rudimentary and usually nonfunctioning in men. Breasts: Anatomy.[3,7]
If there are no additional risk factors, no supplemental screeningScreeningPreoperative Care is recommended.
MRI or US may be used as an adjunct in moderate- or high-risk patientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship.
TransgenderTransgenderPersons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one’s anatomical sex at birth, with or without a desire to undergo sex reassignment procedures.Gender DysphoriapatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship[16]
TransgenderTransgenderPersons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one’s anatomical sex at birth, with or without a desire to undergo sex reassignment procedures.Gender Dysphoria women (male-to-female) at high risk for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer who are 25‒30 years of age with past or current hormone use ≥ 5 years
TransgenderTransgenderPersons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one’s anatomical sex at birth, with or without a desire to undergo sex reassignment procedures.Gender Dysphoria men (female-to-male) with reduction mammoplasty or no chest surgery who are:
At high risk for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer and 25‒30 years of age
At intermediate risk for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer and ≥ 30 years of age
At average risk for breast cancerBreast cancerBreast cancer is a disease characterized by malignant transformation of the epithelial cells of the breast. Breast cancer is the most common form of cancer and 2nd most common cause of cancer-related death among women. Breast Cancer and ≥ 40 years of age
TransgenderTransgenderPersons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one’s anatomical sex at birth, with or without a desire to undergo sex reassignment procedures.Gender Dysphoria women at high risk who are 25‒30 years of age with hormone use < 5 years
TransgenderTransgenderPersons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one’s anatomical sex at birth, with or without a desire to undergo sex reassignment procedures.Gender Dysphoria women at average risk who are ≥ 40 years of age with past or current hormone use ≥ 5 years
TransgenderTransgenderPersons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one’s anatomical sex at birth, with or without a desire to undergo sex reassignment procedures.Gender Dysphoria women at average risk with hormone use < 5 years at any age.
TransgenderTransgenderPersons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one’s anatomical sex at birth, with or without a desire to undergo sex reassignment procedures.Gender Dysphoria men with bilateral mastectomies at any age and any risk level
Male BRCAcarriersCarriersThe Cell: Cell Membrane have a higher risk for breast, prostateProstateThe prostate is a gland in the male reproductive system. The gland surrounds the bladder neck and a portion of the urethra. The prostate is an exocrine gland that produces a weakly acidic secretion, which accounts for roughly 20% of the seminal fluid., and pancreatic cancers:
Monthly breast self-examination starting at age 35
Annual clinical breast exam starting at age 35
Annual mammographyMammographyRadiographic examination of the breast.Breast Cancer Screening can be considered in men with gynecomastiaGynecomastiaGynecomastia is a benign proliferation of male breast glandular ductal tissue, usually bilateral, caused by increased estrogen activity, decreased testosterone activity, or medications. The condition is common and physiological in neonates, adolescent boys, and elderly men. Gynecomastia or increased breast density (evidence is limited).
ProstateProstateThe prostate is a gland in the male reproductive system. The gland surrounds the bladder neck and a portion of the urethra. The prostate is an exocrine gland that produces a weakly acidic secretion, which accounts for roughly 20% of the seminal fluid. cancer screeningScreeningPreoperative Care starting at age 40 for BRCA2carriersCarriersThe Cell: Cell Membrane
Consideration of prostateProstateThe prostate is a gland in the male reproductive system. The gland surrounds the bladder neck and a portion of the urethra. The prostate is an exocrine gland that produces a weakly acidic secretion, which accounts for roughly 20% of the seminal fluid.screeningScreeningPreoperative Care starting at age 40 for BRCA1carriersCarriersThe Cell: Cell Membrane
References
U.S. Preventive Services Task Force. (2016). Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 2016(164), 279–296.
U.S. Preventive Services Task Force. (2019). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer. JAMA, 322(7), 652–665.
American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Gynecology. (2017). Practice bulletin no. 179: breast cancer risk assessment and screening in average-risk women. Obstetrics and Gynecology, 130(1), e1‒e16. https://doi.org/10.1097/AOG.0000000000002158
Oeffinger, K. C., Fontham, E. T., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y. C., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., Wolf, A. M., DeSantis, C., Lortet-Tieulent, J., Andrews, K., Manassaram-Baptiste, D., Saslow, D., Smith, R. A., Brawley, O. W., Wender, R., American Cancer Society. (2015). Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA, 314(15), 1599–1614. https://doi.org/10.1001/jama.2015.12783
American College of Obstetricians and Gynecologists Committee on Practice Bulletins‒Gynecology, & Society of Gynecologic Oncology Committee on Genetics. (2017). Practice bulletin no. 182: hereditary breast and ovarian cancer syndrome. Obstetrics and Gynecology 130(3), e110‒e126.
American College of Radiology. (2017). ACR appropriateness criteria for transgender breast cancer screening. Retrieved September 28, 2022, from https://acsearch.acr.org/docs/3155692/Narrative/
Ibrahim, M., Yadav, S., Ogunleye, F., Zakalik, D. (2018). Male BRCA mutation carriers: clinical characteristics and cancer spectrum. BMC Cancer, 18. https://doi.org/10.1186/s12885-018-4098-y
Qaseem, A., et al. (2019). Screening for breast cancer in average-risk women: A guidance statement from the American College of Physicians. Annals of Internal Medicine, 170(8):547–560. https://www.acpjournals.org/doi/10.7326/m18-214